Summary
Australia's medicines regulator, the TGA, has issued warnings for GLP-1 drugs like Ozempic and Mounjaro due to a potential link to a "rare but severe" eye disorder that could cause blindness. The warning follows 36 reported cases of the condition linked to these treatments.